Still calculating financial ratios manually?
Stop wasting time — let the computer do it!
TherapeuticsMD, Inc. (TXMD) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
951 YAMATO ROAD, SUITE 220 BOCA RATON, FL 33431 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2026 Q1 | 12/31/2025 Q4 | 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 7,733 | 5,745 | 5,059 | ||||||
| Cash and cash equivalent | 7,733 | 5,745 | 5,059 | ||||||
| Prepaid expense | 431 | 1,389 | 1,315 | 1,437 | 1,304 | 1,450 | |||
| Other undisclosed current assets | 6,281 | 13,114 | 12,146 | 5,330 | 5,896 | 10,704 | |||
| Total current assets: | 14,445 | 14,503 | 13,461 | 12,512 | 12,259 | 12,154 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 5,293 | 5,515 | 5,732 | 5,948 | 6,102 | 6,302 | |||
| Intangible asset, including goodwill, after accumulated amortization | 3,761 | 3,914 | 4,043 | 4,138 | 4,321 | 4,428 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 3,761 | 3,914 | 4,043 | 4,138 | 4,321 | 4,428 | |||
| Other noncurrent assets | 444 | 470 | 428 | 211 | 130 | 58 | |||
| Other undisclosed noncurrent assets | 13,713 | 14,269 | 14,840 | 15,427 | 16,010 | 16,610 | |||
| Total noncurrent assets: | 23,211 | 24,168 | 25,043 | 25,724 | 26,563 | 27,398 | |||
| TOTAL ASSETS: | 37,656 | 38,671 | 38,504 | 38,236 | 38,822 | 39,552 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,143 | 1,206 | 1,054 | 945 | 752 | 2,818 | |||
| Accounts payable | 377 | 263 | 350 | 176 | 258 | 234 | |||
| Accrued liabilities | 766 | 943 | 704 | 769 | 494 | 1,195 | |||
| Other undisclosed accounts payable and accrued liabilities | 1,389 | ||||||||
| Disposal group, including discontinued operation | 2,667 | 2,667 | 2,722 | 2,785 | 2,781 | 2,924 | |||
| Other undisclosed current liabilities | 975 | 1,072 | 886 | 1,011 | 1,633 | 234 | |||
| Total current liabilities: | 4,785 | 4,945 | 4,662 | 4,741 | 5,166 | 5,976 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 5,995 | 6,282 | 6,550 | 6,755 | 6,286 | 6,482 | |||
| Other liabilities | 873 | 871 | 832 | 795 | 744 | 705 | |||
| Operating lease, liability | 5,122 | 5,411 | 5,718 | 5,960 | 5,542 | 5,777 | |||
| Total noncurrent liabilities: | 5,995 | 6,282 | 6,550 | 6,755 | 6,286 | 6,482 | |||
| Total liabilities: | 10,780 | 11,227 | 11,212 | 11,496 | 11,452 | 12,458 | |||
| Equity | |||||||||
| Equity, attributable to parent | 26,876 | 27,444 | 27,292 | 26,740 | 27,370 | 27,094 | |||
| Common stock | 11 | 11 | 11 | 11 | 11 | 11 | |||
| Additional paid in capital | 979,256 | 979,205 | 979,205 | 979,204 | 979,181 | 979,157 | |||
| Accumulated deficit | (952,391) | (951,772) | (951,924) | (952,475) | (951,822) | (952,074) | |||
| Total equity: | 26,876 | 27,444 | 27,292 | 26,740 | 27,370 | 27,094 | |||
| TOTAL LIABILITIES AND EQUITY: | 37,656 | 38,671 | 38,504 | 38,236 | 38,822 | 39,552 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2026 Q1 | 12/31/2025 Q4 | 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 893 | 784 | 952 | 393 | 1,761 | |||
| Sublease income | 527 | 534 | 376 | |||||
| Cost of revenue (Financing Interest Expense) | (3) | |||||||
| Other undisclosed gross profit | 8 | |||||||
| Gross profit: | 893 | 784 | 952 | 393 | 1,769 | (3) | ||
| Operating expenses | (2,445) | (1,646) | (1,647) | (1,264) | (986) | (1,406) | ||
| Other undisclosed operating income (loss) | (1,102) | 550 | ||||||
| Operating loss: | (1,552) | (862) | (695) | (871) | (319) | (859) | ||
| Nonoperating income | 972 | 912 | 1,240 | 203 | 402 | 292 | ||
| Interest and debt expense | (1) | (3) | (2) | (2) | ||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (10) | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (581) | 47 | 543 | (670) | 74 | (567) | ||
| Other undisclosed income from continuing operations before income taxes | 1 | 3 | 2 | 2 | 10 | |||
| Income (loss) from continuing operations before income taxes: | (580) | 50 | 545 | (668) | 83 | (567) | ||
| Income tax benefit | 32 | |||||||
| Other undisclosed income (loss) from continuing operations | (32) | 31 | ||||||
| Income (loss) from continuing operations: | (612) | 50 | 545 | (636) | 114 | (567) | ||
| Income (loss) from discontinued operations | (7) | 102 | 6 | (17) | 138 | (42) | ||
| Net income (loss) available to common stockholders, diluted: | (619) | 152 | 551 | (653) | 252 | (609) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2026 Q1 | 12/31/2025 Q4 | 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (619) | 152 | 551 | (653) | 252 | (609) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (619) | 152 | 551 | (653) | 252 | (609) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.
An easy way to get professional financial analysis in one click
Load financial statements → click "Get report" → Your report is ready.
No financial analysis knowledge required!